These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29402549)

  • 1. The Effect of Size and Shape of RNA Nanoparticles on Biodistribution.
    Jasinski DL; Li H; Guo P
    Mol Ther; 2018 Mar; 26(3):784-792. PubMed ID: 29402549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice.
    Haque F; Xu C; Jasinski DL; Li H; Guo P
    Methods Mol Biol; 2017; 1632():359-380. PubMed ID: 28730451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
    Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
    Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA nanoparticle distribution and clearance in the eye after subconjunctival injection with and without thermosensitive hydrogels.
    Shi Z; Li SK; Charoenputtakun P; Liu CY; Jasinski D; Guo P
    J Control Release; 2018 Jan; 270():14-22. PubMed ID: 29170141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophobic Effect from Conjugated Chemicals or Drugs on In Vivo Biodistribution of RNA Nanoparticles.
    Jasinski DL; Yin H; Li Z; Guo P
    Hum Gene Ther; 2018 Jan; 29(1):77-86. PubMed ID: 28557574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA Nanoparticles as Rubber for Compelling Vessel Extravasation to Enhance Tumor Targeting and for Fast Renal Excretion to Reduce Toxicity.
    Ghimire C; Wang H; Li H; Vieweger M; Xu C; Guo P
    ACS Nano; 2020 Oct; 14(10):13180-13191. PubMed ID: 32902260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery.
    Abdelmawla S; Guo S; Zhang L; Pulukuri SM; Patankar P; Conley P; Trebley J; Guo P; Li QX
    Mol Ther; 2011 Jul; 19(7):1312-22. PubMed ID: 21468004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of three-component collision to produce ultrastable pRNA three-way junction of Phi29 DNA-packaging motor by kinetic assessment.
    Binzel DW; Khisamutdinov E; Vieweger M; Ortega J; Li J; Guo P
    RNA; 2016 Nov; 22(11):1710-1718. PubMed ID: 27672132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular delivery of pRNA nanoparticles: distribution and clearance after subconjunctival injection.
    Feng L; Li SK; Liu H; Liu CY; LaSance K; Haque F; Shu D; Guo P
    Pharm Res; 2014 Apr; 31(4):1046-58. PubMed ID: 24297069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grouping of ferritin and gold nanoparticles conjugated to pRNA of the phage phi29 DNA-packaging motor.
    Moll WD; Guo P
    J Nanosci Nanotechnol; 2007 Sep; 7(9):3257-67. PubMed ID: 18019159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeled RNA Nanoparticles for Highly Specific Targeting and Efficient Tumor Accumulation with Favorable
    Wang H; Guo P
    Mol Pharm; 2021 Aug; 18(8):2924-2934. PubMed ID: 34212728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and comparison of thermal stability of phosphorothioate-DNA, DNA, RNA, 2'-F RNA, and LNA in the context of Phi29 pRNA 3WJ.
    Piao X; Wang H; Binzel DW; Guo P
    RNA; 2018 Jan; 24(1):67-76. PubMed ID: 29051199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNA.
    Zhang H; Endrizzi JA; Shu Y; Haque F; Sauter C; Shlyakhtenko LS; Lyubchenko Y; Guo P; Chi YI
    RNA; 2013 Sep; 19(9):1226-37. PubMed ID: 23884902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
    Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
    RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for Single-Molecule Sensing and Detection Using Bacteriophage Phi29 DNA Packaging Motor.
    Haque F; Zhang H; Wang S; Chang CL; Savran C; Guo P
    Methods Mol Biol; 2018; 1805():423-450. PubMed ID: 29971730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of RNA-Quantum Dot Chimera for Nanoscale Resistive Biomemory Application.
    Lee T; Yagati AK; Pi F; Sharma A; Choi JW; Guo P
    ACS Nano; 2015 Jul; 9(7):6675-82. PubMed ID: 26135474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.
    Shu Y; Shu D; Haque F; Guo P
    Nat Protoc; 2013 Sep; 8(9):1635-59. PubMed ID: 23928498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for construction and characterization of simple or special multifunctional RNA nanoparticles based on the 3WJ of phi29 DNA packaging motor.
    Guo S; Piao X; Li H; Guo P
    Methods; 2018 Jul; 143():121-133. PubMed ID: 29530505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
    Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
    ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mg
    Chen L; Li J
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.